A review of the latest research medications and information on the inflammatory, molecular, pathological, and targeted aspects of breast cancer

Cancer is a complex illness involving wide variety of genes and proteins regulated by various epigenetic hereditary transcriptional alterations. Several molecular alterations characterize breast cancer (BC), one the most lethal forms female malignancy. As western lifestyles become more common, cities expand, people live longer, BC’s prevalence death rate continue to rise. Despite availability several cutting-edge methods for diagnosing treating BC, it continues be leading cause mortality among women. The clinical, pathological, aspects BC are all highlighted in this overview. In addition, involvement risk factors, biomarkers, immunotherapy, experimental medications through tumor targets immune systems treatment has been discussed. problems future views also detail many techniques targeting using nanocarriers, including clinical trials these agents.